Thursz MR - Search Results

1

Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.

Nayagam S, de Villiers MJ, Shimakawa Y, Lemoine M, Thursz MR, Walsh N, Hallett TB. Nayagam S, et al. Among authors: thursz mr. Lancet Gastroenterol Hepatol. 2023 Jul;8(7):635-645. doi: 10.1016/S2468-1253(23)00074-2. Epub 2023 May 5. Lancet Gastroenterol Hepatol. 2023. PMID: 37150181 Free article.

2

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.

Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Suso P, Tamba S, Njie R, Njai H, Lemoine M, Hallett TB, Thursz M. Nayagam S, et al. Lancet Glob Health. 2016 Aug;4(8):e568-78. doi: 10.1016/S2214-109X(16)30101-2. Lancet Glob Health. 2016. PMID: 27443782 Free article.

3

Requirements for global elimination of hepatitis B: a modelling study.

Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, Hallett TB. Nayagam S, et al. Lancet Infect Dis. 2016 Dec;16(12):1399-1408. doi: 10.1016/S1473-3099(16)30204-3. Epub 2016 Sep 13. Lancet Infect Dis. 2016. PMID: 27638356 Free article.

4

Battlefield against hepatitis B infection and HCC in Africa.

Lemoine M, Thursz MR. Lemoine M, et al. Among authors: thursz mr. J Hepatol. 2017 Mar;66(3):645-654. doi: 10.1016/j.jhep.2016.10.013. Epub 2016 Oct 19. J Hepatol. 2017. PMID: 27771453 Free article. Review.

5

Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.

Howell J, Van Gemert C, Lemoine M, Thursz M, Hellard M. Howell J, et al. J Gastroenterol Hepatol. 2014 Nov;29(11):1854-66. doi: 10.1111/jgh.12684. J Gastroenterol Hepatol. 2014. PMID: 25131570

6

Viral hepatitis: Scaling up HCV treatment in resource-limited countries.

Lemoine M, Thursz M. Lemoine M, et al. Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):193-4. doi: 10.1038/nrgastro.2015.31. Epub 2015 Feb 24. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25708046 No abstract available.

7

Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia.

Shimakawa Y, Lemoine M, Bottomley C, Njai HF, Ndow G, Jatta A, Tamba S, Bojang L, Taal M, Nyan O, D'Alessandro U, Njie R, Thursz M, Hall AJ. Shimakawa Y, et al. Liver Int. 2015 Oct;35(10):2318-26. doi: 10.1111/liv.12814. Epub 2015 Mar 11. Liver Int. 2015. PMID: 25728498

8

Mother-to-child transmission of hepatitis B in sub-Saharan Africa.

Shimakawa Y, Toure-Kane C, Mendy M, Thursz M, Lemoine M. Shimakawa Y, et al. Lancet Infect Dis. 2016 Jan;16(1):19-20. doi: 10.1016/S1473-3099(15)00469-7. Lancet Infect Dis. 2016. PMID: 26738828 No abstract available.

9

Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba S, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D'Alessandro U, Mendy M, Thursz MR; PROLIFICA investigators. Lemoine M, et al. Among authors: thursz mr. Lancet Glob Health. 2016 Aug;4(8):e559-67. doi: 10.1016/S2214-109X(16)30130-9. Lancet Glob Health. 2016. PMID: 27443781 Free article. Clinical Trial.

10

Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa - Authors' reply.

Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Lemoine M, Hallett TB, Thursz M. Nayagam S, et al. Lancet Glob Health. 2017 Jan;5(1):e35. doi: 10.1016/S2214-109X(16)30285-6. Lancet Glob Health. 2017. PMID: 27955781 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page